GSK plcLSE: GSK

Board and Committee Changes

· Issued by GSK plc

GSK plc

Board Committee Changes

GSK plc today announces the following change to its Board Committee membership:

Having completed over five years as Science Committee Chair, Dr Jesse Goodman will end his rotation and Dr Hal Dietz will succeed him as Committee Chair with effect from 1 January 2023.

V A Whyte

Company Secretary

15 December 2022

GSK plc on 6ix

Story so far

Earlier from GSK

Later from GSK

All GSK news releases